More likely, IMO, is that ARIA thinks the goodwill from free treatment can be leveraged somehow to get a better outcome from the FDA. In reality, the FDA probably isn't influenced by any of this, however.
It is probably Ariad's goodwill towards the cancer patients against the FDA's badwill towards them. Ariad probably knows the FDA won't be influenced by the goodwill.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.